Home / Transcranial Direct Current Stimulation
Mansa Clinic in Aundh, Pune offers tDCS (transcranial direct current stimulation) - a non-invasive, evidence-based brain stimulation therapy that uses low-level electrical current to modulate neural activity. tDCS is used at the clinic for treatment-resistant depression, OCD, cognitive rehabilitation in older adults, and as an adjunct to standard psychiatric care - under the supervision of MD-qualified psychiatrists.
Transcranial direct current stimulation (tDCS) is a form of non-invasive neurostimulation that uses a mild, constant electrical current - typically 1–2 milliamps - delivered through electrodes placed on the scalp. This current modulates the resting membrane potential of neurons in targeted brain regions, making them either more or less likely to fire.
The clinical effect is not immediate stimulation in the way of electroconvulsive therapy (ECT). Rather, tDCS works by shifting the excitability of specific neural circuits over a series of sessions, producing gradual but sustained changes in mood, cognition, and behaviour. It is painless, does not require anaesthesia, and can be administered in a clinical setting without hospital admission.
tDCS is now listed in multiple international treatment guidelines, including those of the International Federation of Clinical Neurophysiology (2017) and the Brazilian Committee for tDCS (2021). Research published in journals including Neuropsychopharmacology, Brain Stimulation, and the European Journal of Neuroscience supports its use in depression, OCD, and cognitive rehabilitation.
Approximately 30% of people with major depressive disorder do not respond adequately to first- or second-line antidepressants. For this group, tDCS offers a non-pharmacological option with a meaningful evidence base. tDCS targeting the left dorsolateral prefrontal cortex (DLPFC) has shown statistically significant antidepressant effects in multiple randomised controlled trials. At Mansa Clinic, tDCS for depression is always used as part of a broader psychiatric management plan - not as a standalone intervention.
Evidence supports the use of tDCS as an adjunct to ERP therapy for OCD - specifically by modulating activity in the supplementary motor area and orbitofrontal cortex, regions implicated in the compulsive response cycle. For patients who have completed ERP and achieved partial but incomplete symptom reduction, tDCS offers a well-tolerated way to consolidate progress.
tDCS targeting prefrontal regions has demonstrated improvement in working memory, attention, and executive function in studies involving older adults with mild cognitive impairment. At Mansa Clinic, tDCS for cognitive rehabilitation is offered as part of our geriatric psychiatry and dementia care protocols, alongside neuropsychological assessment and pharmacological management.
Emerging evidence supports tDCS as a complement to medication management in ADHD, particularly for improving working memory and inhibitory control. This is offered at Mansa Clinic for suitable patients following a full psychiatric assessment.
tDCS uses low, constant current to modulate neural excitability. It is painless, does not require sedation, and is administered in a clinic setting. Evidence is strongest for depression and OCD. TMS (transcranial magnetic stimulation) uses magnetic pulses to induce electrical currents in targeted brain regions. More powerful than tDCS, with a stronger evidence base for treatment-resistant depression, but requires specialised equipment and is typically more expensive.
ECT (electroconvulsive therapy) involves inducing a brief, controlled seizure under general anaesthesia. It is the most effective treatment for severe, treatment-resistant depression and certain psychotic conditions - but requires hospital admission and carries higher short-term cognitive side effects.
A standard tDCS session at Mansa Clinic takes 20–30 minutes. You sit comfortably in a chair. Two moistened sponge electrodes are placed on specific areas of your scalp using a headband - the placement is determined by your diagnosis and the brain region being targeted. A mild current is then applied for 20 minutes. Most people feel only a faint tingling or warmth at the electrode sites.
A standard treatment course is typically 10–20 sessions, administered daily or on alternating days. Dr. Baste reviews your response at intervals and adjusts the plan if needed. Sessions can be combined with a therapy appointment on the same day.
tDCS has been studied in thousands of participants in clinical trials across the world and is considered safe when administered by trained clinicians at approved parameters. Side effects are typically mild and transient - tingling, mild headache, or slight redness at the electrode site. There are no known long-term adverse effects at the parameters used clinically explicit, informed consent.
Contraindications include a history of epilepsy, metal implants in the head, or skin conditions at the electrode sites. Dr. Baste conducts a full medical and psychiatric assessment before recommending tDCS to ensure it is appropriate for you.